Clinical Trial Update: Compassionate Access of the Miltenyi Device for CD34+ Cell Selection [NA]

View source ↗

Summary

The trial update notes compassionate-access to Miltenyi's CD34+ cell selection device for hematopoietic stem cell transplantation, with recruitment currently on…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematopoietic Stem Cell Transplantation

Drugs mentioned

• CliniMACS CD34+ Cell Selection Device (CD34+ cell selection device)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Blood And Marrow Transplantation | NA | Status: RECRUITING